GlassScriptPhysician profile
Michael Scott Ingber
NPI 1861606329
$529,942.28
in general payments reported to CMS, 2019-2025
51 companies · $1,505 in 2025
The $1,505 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $7,346 · 2021: $441K · 2022: $23K · 2023: $42K · 2024: $3,422 · 2025: $1,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $22K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $4,997 · Travel and Lodging: $2,390 · Education: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $22,031.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,840.00 |
| Food and Beverage | $4,997.15 |
| Travel and Lodging | $2,390.10 |
| Education | $249.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $431,026.99 | 2021-2024 | Channel Drain |
| Allergan, INC. | $35,091.67 | 2019-2022 | |
| Medtronic, INC. | $24,495.71 | 2021-2025 | Interstim, Altaviva, Intellis Adaptivestim |
| Medtronic USA, INC. | $8,699.55 | 2019-2020 | |
| Abbvie INC. | $7,885.67 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $7,658.01 | 2023-2025 | Gemtesa |
| Coloplast Corp | $5,011.35 | 2019-2025 | Altis, Speedicath |
| Caldera Medical, INC | $2,793.68 | 2019-2023 | Desara |
| Urovant Sciences INC | $2,120.20 | 2021-2022 | |
| Astellas Pharma US INC | $1,187.71 | 2019-2025 | Veozah, Myrbetriq |
| Axonics, INC. | $897.58 | 2020-2023 | Axonics |
| Valencia Technologies Corporation | $794.16 | 2022 | |
| Femselect INC. | $301.71 | 2023 | Enplace |
| Millicent US INC | $225.27 | 2019-2025 | Intrarosa, Femring |
| Bluewind Medical | $170.48 | 2024-2025 | Revi |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $130.60 | 2019-2020 | |
| Tolmar, INC. | $129.41 | 2024-2025 | Jatenzo, Eligard |
| Pfizer INC. | $113.77 | 2019-2024 | |
| Antares Pharma, INC. | $110.90 | 2021-2025 | Xyosted |
| Edap Technomed INC | $100.00 | 2023 | |
| Neotract INC. | $97.89 | 2020 | |
| 180 Medical, INC. | $96.83 | 2019-2023 | |
| Amag Pharmaceuticals, INC. | $85.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $83.42 | 2022-2023 | Seglentis |
| Intuitive Surgical, INC. | $63.89 | 2023-2024 | Da Vinci Surgical System |
| Urogen Pharma, INC. | $47.70 | 2021-2023 | Jelmyto |
| Mayne Pharma Commercial LLC | $46.26 | 2023 | |
| Davol INC. | $36.64 | 2021 | |
| Ethicon US, LLC | $34.76 | 2025 | Echelon Flex |
| Janssen Biotech, INC. | $31.47 | 2019-2024 | Erleada, Balversa, Akeega |
| Boston Scientific Corporation | $31.05 | 2025 | General - Female Sui |
| Ferring Pharmaceuticals INC. | $27.12 | 2019 | |
| Axogen | $26.85 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $26.81 | 2020 | |
| Laborie Medical Technologies Corp. | $20.67 | 2022 | |
| Olympus America INC. | $20.00 | 2019 | |
| Avation Medical, INC. | $18.60 | 2024 | Vivally |
| Endo USA, INC. | $18.36 | 2025 | Xiaflex |
| Teleflex LLC | $18.05 | 2025 | Urolift |
| Calyxo, INC. | $17.99 | 2025 | Cvac Aspiration System |
| Photocure INC | $17.96 | 2023 | Cysview |
| Solta Medical, A Division of Bausch Health US, LLC | $17.84 | 2019 | |
| Ambu INC. | $17.83 | 2021 | |
| Duchesnay USA Incorporated | $14.89 | 2019 | |
| Telix Pharmaceuticals | $14.86 | 2023 | Illuccix |
| Zyla Life Sciences, INC. | $14.62 | 2019 | |
| Progenics Pharmaceuticals, INC. | $13.96 | 2023 | Pylarify |
| Acerus Pharmaceuticals Corporation | $13.00 | 2022 | |
| Celgene Corporation | $11.91 | 2020 | |
| Allegis Pharmaceuticals, LLC | $11.63 | 2023 | Urimar-T Caps |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$297.12 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ingber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.